DVP II Life sciences & health 4-14 May 2014. 2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different.

Slides:



Advertisements
Similar presentations
Ferring Controlled Therapeutics
Advertisements

Engaging with Employers UKSPA Member Meeting Oct 6th/7th John Holton Strategy Director Cogent Sector Skills Council.
Creation of Pilot IP Fund Liis Käosaar-Sasi Dorel Tamm.
Microsoft Business Technology Center Microsoft Business-Technology Center Establishment of MSBTC and the Possibility.
2nd Panel, Best Practices: “ IPR in Successful University-Industry Collaborations” Dr. Tamar Raz, CEO Hadasit, the Technology Transfer Company of Hadassah.
SGC OxfordSGC TorontoSGC Stockholm How Canada might develop its drug discovery sector.
Undergraduate and MSc courses in the Division of Biosciences Dr. Christian Rudolph
2015. MITA. All rights reserved.````` Lithuanian Country Report Gintarė Narakienė The Agency for Science, Innovation and Technology.
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
DR EBTISSAM AL-MADI Management of Information in health care organizations.
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Denmark HEI All Perspectives Prepared by Prof.
Southern Indiana Life Sciences Training Institute Sengyong Lee Ph.D. Associate Professor/Program Chair Ivy Tech Community College Bloomington, IN
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE LIFE SCIENCES Anthony Atkin (Research Impact.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Services for Employers Services for Employers at the University of Derby “Transforming your People Developing your Business”
The Biotechnology Program at Hudson Valley Community College
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
The Infectious Diseases Institute Kampala, Uganda InfoPoverty World Conference United Nations InfoPoverty World Conference United Nations Robert L. Mallett.
Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Bioinformatics Education: Training a New Generation of Professionals Patricia Dombrowski May 2005.
INTRODUCTION TO RA.
Technology Based Economic Development in West Virginia Gaps, Strengths and Recommendations 2008 Create WV Conference.
Leveraging Government support and global partnerships to increase biologics manufacturing capacity.
September 2011 Вивари (в том числе spf-зона) Лаборатория Офисная зона Учебная зона (аудитории) September 2013.
1 Developing Medical Education Research Karen V Mann, PhD Division of Medical Education Dalhousie University.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
Telematikplattform für Medizinische Forschungsnetze (TMF) e.V. TMF – A Common Platform for Medical Research Networks in Germany Improving the Organisation.
Research Program Overview National Institute on Disability and Rehabilitation Research Robert J. Jaeger, Ph.D. Interagency and International Affairs Interagency.
S&T and Innovation Policy in the Republic of Armenia Innovation Programs Division, SCS RA “Development of Coherent Innovation Policy in South Caucasian.
State University of New York at Stony Brook Clinton Rubin, Ph.D. Professor & Chair Department of Biomedical Engineering Forum on Innovation and Entrepreneurship.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
An introduction to The University of Auckland’s Knowledge Transfer Company Dr Peter Lee, CEO.
Training the future leaders of the biomedical engineering field – world-class research, experience of clinical translation and exposure to making inventions.
Academic Pathway Pharmaceutical Sciences NTUSPAA-NA Annual Event San Francisco, CA, August 6, 2005 Diana Shu-Lian Chow, Ph.D. Associate Professor of Pharmaceutics.
Technology Transfer in Lithuania: Has a Time Come to Boost Intellectual Property Commercialization? Gailė Sakalaitė Lawyer of Public Entity “Sunrise Valley"
Discussion points from the Science|Business Executive Forum UCL, 5 November Technology 2. Money 3. People 4. Global Trends.
THE BIOTECHNOLOGY WORKPLACE. OVERVIEW Biotechnology workplaces Laboratories.
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Finnland HEI All Perspectives Prepared by Prof.
1970s Functional Genetics From … Functional Genomics … to … Evolution of.
Bridge to a New Economy Old economy Low Average salaries Start-ups capital intensive Plants close or move Based on a pyramid style organizational structure.
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Lithuania HEI All Perspectives Prepared by.
“AN IDEA FOR INNOVATIVE COMPANY” Competition – Incubation – Financing – Growth Tomasz Wiśniewski Salamanca, 23 – 24 June 2005.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Slovenia HEI All Perspectives Prepared by Prof.
Intellectual Property Valorization
Health + Data Accelerator Emma Cheshire Co Founder and CEO
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Croatia HEI All Perspectives Prepared by Prof.
Haphe.eurashe.eu 1 Presenter NameEvent Name HAPHE Survey Results First results – EU Level versus Czech Republic HEI All Perspectives Prepared.
1 An Overview of Process and Procedures for Health IT Collaboration GSA Office of Citizen Services and Communications Intergovernmental Solutions Division.
1 Extending the Wisconsin Idea UW Funding Opportunities for Technologies with Promising Potential.
The Basque Foundation for Health and Innovation Research Demotek Demonstration Unit of Innovative Technologies in Health An opportunity for.
Everywhere you look Health Science touches your life.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
I am in the Biotechnology industry
Ensuring Successful Technology Transfer for Clinical Manufacture
Life Science Specialists for the Oresund Region
Jocelyn Rose Director, Center for Life Science Enterprise.
Science parks and technological support at ELI Beamlines
Clinical Research Coordinator Training Initiative
Gestora brasileiro focada exclusivamente na área da saúde.
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
Beyond Academia.
Career Opportunities In Pharmacy. What is Pharmacy Pharmacy is the science and technique of preparing, researching, and distributing medicinal drugs.
Penn State Entrepreneurship
9th October, 2018 Arno Meerman
9th October, 2018 Arno Meerman
Presentation transcript:

DVP II Life sciences & health 4-14 May 2014

2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different courtiers Experience the Netherlands first hand Gain insight into the country’s history, culture and people Obtain relevant knowledge and worthwhile contacts to satisfy personal and professional needs and interests Pursue mutually beneficial opportunities, leads, contacts, projects, etc., with Dutch individuals and organisations

3

4 Life Sciences in the Netherlands

5

6 8 University Medical Centers, 14 Research Universities (incl. 3 Technical Universities), 137 general hospitals Biobanks and patient cohorts for research purposes Life Sciences in the Netherlands

7

8 Dedicated Bio Science Park (since 1984) with a clear focus Specialisation in biomedical and bio molecular life sciences; biopharmaceutical production 90 life science companies with ± 3,800 employees ~16,000 employees in total working at 1 location LUMC with ± 6,800 employees in total another 6 academic/education centers with ± 2,600 employees in life science related jobs the largest number of life sciences start-ups 2 musea: Naturalis Biodiversity Center and Corpus Experience 2 skilled labour pools

Facilities Expat centre Naturalis Biodiversity Center Netherlands Centre for Electron Nanoscopy Biotech Training Facility Realistic biopharmaceutical plant, for training, education and demonstration Bridge gap between schooling and practice Location close to education institutes and industry Construction starts summer 2014, opening autumn 2015 Investment ~ € 10 M

Service companies  Proxy Laboratories: QA, QC, stability testing, assay development, validation  Microsafe Laboratories: microbiology testing  Galapagos: target discovery  Xendo: process development, drug development, validation, RA, GMP, pharmaceutical engineering, clinical trials, bio analytical service  Batavia Bioservices: early process development  OctoPlus/Dr. Reddy’s: drug delivery technology  TLC: drug delivery technology  TNO Quality of life: drug development  BaseClear: DNA sequencing, forensic support  CHDR: clinical trials  BioTop Medical: regulatory Affairs  ServiceXS: genomics service center  LifeScienceGo!: business resources  Chiltern: full clinical research services from early phase to late phase  Halix: CMO

11 Center for Human Drug Research

12 Center for Human Drug Research

13 Mission of both centres is to maximise effective utilisation of new IP (social, economic and financial drivers are relevant) Evaluate & protect new inventions Identify and negotiate licensees Assist in new company formation (mentoring, pre-seed & seed funds) Advise university on EU and other major research funding opportunities Negotiate research contracts, particularly complex public/private partnerships Leiden Technology Transfer Office Leiden University and Leiden University Medical Centre

14

15 Institute for Health Policy and Management, Erasmus University

16